These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21306168)

  • 1. Incorporation of a bioactive reverse-turn heterocycle into a peptide template using solid-phase synthesis to probe melanocortin receptor selectivity and ligand conformations by 2D 1H NMR.
    Singh A; Wilczynski A; Holder JR; Witek RM; Dirain ML; Xiang Z; Edison AS; Haskell-Luevano C
    J Med Chem; 2011 Mar; 54(5):1379-90. PubMed ID: 21306168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of the unique and potent agouti-related protein (AGRP)-melanocortin chimeric Tyr-c[beta-Asp-His-DPhe-Arg-Trp-Asn-Ala-Phe-Dpr]-Tyr-NH2 peptide template.
    Wilczynski A; Wilson KR; Scott JW; Edison AS; Haskell-Luevano C
    J Med Chem; 2005 Apr; 48(8):3060-75. PubMed ID: 15828845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric NDP-MSH and MTII melanocortin peptides with agouti-related protein (AGRP) Arg-Phe-Phe amino acids possess agonist melanocortin receptor activity.
    Joseph CG; Wilczynski A; Holder JR; Xiang Z; Bauzo RM; Scott JW; Haskell-Luevano C
    Peptides; 2003 Dec; 24(12):1899-908. PubMed ID: 15127941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel agouti-related-protein-based melanocortin-1 receptor antagonist.
    Thirumoorthy R; Holder JR; Bauzo RM; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2001 Nov; 44(24):4114-24. PubMed ID: 11708914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-D-Phe-Arg-Trp-NH2 at the mouse melanocortin receptors. 4. Modifications at the Trp position.
    Holder JR; Xiang Z; Bauzo RM; Haskell-Luevano C
    J Med Chem; 2002 Dec; 45(26):5736-44. PubMed ID: 12477357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors. 1. Modifications at the His position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jun; 45(13):2801-10. PubMed ID: 12061882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist.
    Wilczynski A; Wang XS; Bauzo RM; Xiang Z; Shaw AM; Millard WJ; Richards NG; Edison AS; Haskell-Luevano C
    J Med Chem; 2004 Nov; 47(23):5662-73. PubMed ID: 15509165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH.
    Boeglin D; Xiang Z; Sorenson NB; Wood MS; Haskell-Luevano C; Lubell WD
    Chem Biol Drug Des; 2006 Apr; 67(4):275-83. PubMed ID: 16629825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biophysical, and pharmacological evaluation of the melanocortin agonist AST3-88: modifications of peptide backbone at Trp 7 position lead to a potent, selective, and stable ligand of the melanocortin 4 receptor (MC4R).
    Singh A; Dirain ML; Wilczynski A; Chen C; Gosnell BA; Levine AS; Edison AS; Haskell-Luevano C
    ACS Chem Neurosci; 2014 Oct; 5(10):1020-31. PubMed ID: 25141170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytes.
    Todorovic A; Holder JR; Bauzo RM; Scott JW; Kavanagh R; Abdel-Malek Z; Haskell-Luevano C
    J Med Chem; 2005 May; 48(9):3328-36. PubMed ID: 15857138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Macrocyclic Agouti-Related Protein/[Nle
    Ericson MD; Freeman KT; Schnell SM; Haskell-Luevano C
    J Med Chem; 2017 Jan; 60(2):805-813. PubMed ID: 28045525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of the melanocortin tetrapeptide Ac-His-DPhe-Arg-Trp-NH(2) at the mouse melanocortin receptors: part 2 modifications at the Phe position.
    Holder JR; Bauzo RM; Xiang Z; Haskell-Luevano C
    J Med Chem; 2002 Jul; 45(14):3073-81. PubMed ID: 12086493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,2,3-Triazole Rings as a Disulfide Bond Mimetic in Chimeric AGRP-Melanocortin Peptides: Design, Synthesis, and Functional Characterization.
    Tala SR; Singh A; Lensing CJ; Schnell SM; Freeman KT; Rocca JR; Haskell-Luevano C
    ACS Chem Neurosci; 2018 May; 9(5):1001-1013. PubMed ID: 29257879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor.
    Ericson MD; Freeman KT; Schnell SM; Fleming KA; Haskell-Luevano C
    J Med Chem; 2017 Oct; 60(19):8103-8114. PubMed ID: 28813605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles.
    Ericson MD; Koerperich ZM; Freeman KT; Fleming KA; Haskell-Luevano C
    ACS Chem Neurosci; 2018 Dec; 9(12):3015-3023. PubMed ID: 29924583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of cyclic peptides with biological activities from biologically active peptides: the case of peptide modulators of melanocortin receptors.
    Hruby VJ
    Biopolymers; 2016 Nov; 106(6):884-888. PubMed ID: 27486849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-turn secondary structure and melanocortin ligands.
    Haslach EM; Schaub JW; Haskell-Luevano C
    Bioorg Med Chem; 2009 Feb; 17(3):952-8. PubMed ID: 18343128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships (SAR) of melanocortin and agouti-related (AGRP) peptides.
    Singh A; Haslach EM; Haskell-Luevano C
    Adv Exp Med Biol; 2010; 681():1-18. PubMed ID: 21222256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a β-Hairpin Octapeptide, c[Pro-Arg-Phe-Phe-Dap-Ala-Phe-DPro], Mimetic of Agouti-Related Protein(87-132) [AGRP(87-132)] with Equipotent Mouse Melanocortin-4 Receptor (mMC4R) Antagonist Pharmacology.
    Ericson MD; Wilczynski A; Sorensen NB; Xiang Z; Haskell-Luevano C
    J Med Chem; 2015 Jun; 58(11):4638-47. PubMed ID: 25898270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.